Your cart

There are no items in your shopping cart

GSK 3787

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1628

CAS [188591-46-0]

MF C15H12ClF3N2O3S
MW 392.78

  • Purity: 99%
  • Soluble in DMSO

GSK 3787

Description

Selective and irreversible peroxisome proliferator-activated receptor (PPARδ) antagonist
Order
Size Unit Price Stock
10 mg €90.00 In Stock
50 mg €310.00 In Stock
Special Offers
Size Unit Price Stock
2 x 10 mg €140.00 In Stock
2 x 50 mg €500.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
1227 WY 14643 PPARα agonist €45.00
1237 GW 7647 PPARα agonist €95.00
1567 KRP 297 PPARα agonist; PPARγ agonist €110.00
1950 CDDO A potent multifunctional anti-tumor agent. PPAR-γ agonist €80.00
2019 INT 131 Selective PPARγ modulator (partial agonist) €110.00
2114 CP 775146 Potent and selective PPARα agonist €85.00
2262 GW 9662 Selective PPARγ antagonist €60.00
2379 ZLN 005 Selective transcriptional regulator of peroxisome PPAR-γ coactivator-1α (PGC-1α). €50.00
2402 MHY 908 Dual PPARα/γ agonist, and potent inhibitor of mushroom tyrosinase €95.00
2443 Rosiglitazone PPARγ agonist; antidiabetic drug and stem cell differentiator €95.00
2533 Hydroxypioglitazone Active metabolite of Pioglitazone (M-IV), a PPARγ agonist €180.00
2686 FH535 Dual inhibitor of PPAR and Wnt/β-catenin signaling €75.00
2706 FH535 sodium salt Dual inhibitor of PPAR and Wnt/β-catenin signaling €80.00
2727 Elafibranor Dual PPARα/δ agonist €90.00
2814 MHY 553 PPARα agonist €95.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...